Eisai and Quintiles Enter into a Strategic Collaboration to Develop Eisai's Anticancer Compounds

  Tokyo, Oct 30, 2009 - (JCN Newswire) - Eisai Co., Ltd. today announced that the company has concluded a strategic collaboration agreement with Quintiles, a world leading biopharmaceutical services company, to develop six anticancer compounds in its oncology pipeline to further expedite its Product Creation Strategy for the oncology-related disease area.  

Sydney

  [ Change ]
 
Today

Max: 19°
Shower or two.
Tomorrow

Min: 13°
Max: 20°
Possible shower.
 

Account

Login

To access your account and listings



Remember me
   
   
   
 
 
Find Hunter Valley accommodation online